June 26, 2025 | BeingRareTogether, CLD, CLDSummit, HighHopes, RareDisease, collaboration

Medscape Education is a proud sponsor of the inaugural 2025 Cholestatic Liver Disease Summit, taking place June 26–28 in Aurora, Colorado, at the Hyatt Regency Aurora-Denver Conference Center. Hosted in partnership with Children’s Hospital Colorado, a national leader in cholestatic liver disease treatment and research, this summit represents a powerful step forward for families, clinicians, researchers, and advocates actively working to improve the lives of those affected by rare liver conditions.
This first-of-its-kind event brings together a diverse community focused on rare cholestatic liver diseases. Over three days, the summit will include a Scientific Meeting, Research Roundtable, and a Patient & Family Conference, designed to foster collaboration across disciplines and improve care for rare liver disease communities.
Medscape Education’s sponsorship reflects our deep commitment to supporting underserved and complex disease areas through trusted, evidence-based education. We are especially honored to collaborate with key advocacy organizations, such as the Alagille Syndrome Alliance (ALGSA), Biliary Atresia Research and Education (BARE), and the PFIC Advocacy & Resource Network, Inc., whose efforts continue to drive awareness, research, and hope across these rare conditions.
Rare liver diseases often take 6 to 8 years to be accurately diagnosed. Through education, we aim to help shorten this journey. To support ongoing learning and clinical excellence in rare diseases, we have developed a dedicated learning center for healthcare professionals, created in collaboration with rare disease organizations and leading experts. Our Pathways in Rare Disease initiative is designed to help clinicians recognize the early signs of rare diseases and apply the latest insights in diagnosis and management in clinical practice.
This Summit offers a unique opportunity to bring scientists, clinicians, industry, patients, and families together to bridge knowledge gaps, accelerate research, and build a future of High Hopes for those impacted by cholestatic liver disease. Medscape Education is proud to stand alongside this community as we work together to transform rare disease care through knowledge, compassion, and collaboration.
For more information on this collaboration and future rare disease education, please contact Jennifer Bomberger.
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
The Medscape Division of Public Health announced the launch of the "Where Public Health Meets Practice" Learning Center, a dedicated educational destination on Medscape.org. The new center serves as...
Rare diseases are individually uncommon, yet together they affect an estimated 300 million+ people worldwide and touch the lives of over one billion when families and caregivers are included. For...
For the millions of people living with a rare disease, the path to a diagnosis (if ever received) is often a long and frustrating odyssey. This delay is frequently driven...
In the world of rare diseases, success is often measured by the speed of diagnosis. However, for women facing rare liver conditions like Intrahepatic Cholestasis of Pregnancy (ICP), the medical...
A February Focus on the Heart While February is known as the month of love, it is also National Heart Month, a time for highlighting the importance of cardiovascular health....
Join the Medscape team in Atlanta, February 16–19, 2026, as Alliance celebrates 50 years of excellence in continuing education for health professionals. We’re bringing our 3 decades of experience in...
While obstructive sleep apnea (OSA) affects approximately 32% of US adults—nearly 80 million people—it remains an "epidemic hiding in plain sight". Perhaps most staggering is that 90% of women with...
For decades, modern medicine has treated the mouth and the body as separate entities. But for Dr. Nieca Goldberg, a renowned cardiologist, and Dr. Maria Ryan, Chief Clinical Officer at...
On December 5, MAPS hosted an educational webinar exploring recent research in Alzheimer’s disease (AD) screening, testing, and treatment. Experts from Komodo Health and Medscape shared findings from their...
Discover how AI-powered tools are transforming rare disease diagnosis, patient care, and clinical decision-making.
